Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

WuXi Biologics to Raise up to $513 Million in Hong Kong IPO

publication date: May 25, 2017
According to sources, the upcoming Hong Kong IPO for WuXi Biologics, a CRO/CMO, will raise up to $513 million. That values WuXi's biologics subsidiary at $2 billion, if WuXi follows the common practice of offering 25% of its shares (Hong Kong requires that companies must offer at least that much in an IPO). WuXi Biologics filed for the IPO in January, but the filing did not contain details of the offering. WuXi has still not announced these details officially, though the reports sound definitive. The $513 million transaction is a large increase over the $300 million January whisper number. Preparations for the IPO are expected to launch soon. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here